TapewireFind a company

person · Reporting owner

Aspinall Mara G.

Disclosed activity across 4 companies

Tapewire entity
79772
SEC CIK
0001623049

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DA32 Life Science Tech Acquisition Corp.DALS · Entity 110669DirectorJuly 27, 2021July 27, 2021
ORASURE TECHNOLOGIES INCOSUR · Entity 6152DirectorMay 13, 2025May 15, 2025
Veradigm Inc.MDRX · Entity 13670DirectorMay 25, 2021May 27, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DA32 Life Science Tech Acquisition Corp.

Report date July 27, 2021 · Filed July 27, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B Common StockSEC Table II · derivative / convertible securityDirectNot disclosed Reported balance Holding disclosure · report date 2021-07-27 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.

ORASURE TECHNOLOGIES INC

Report date May 13, 2025 · Filed May 15, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect178,758 Ending reported balance After 2025-05-14 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2025-05-13 · Tax withholding · Disposed 6,666 · Balance 107,741

F1: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

Row 2 · 2025-05-14 · Grant · Acquired 71,017 · Balance 178,758

F2: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 14, 2026, or (ii) immediately prior to the commencement of the Company's 2026 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

F2: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 14, 2026, or (ii) immediately prior to the commencement of the Company's 2026 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Veradigm Inc.

Report date May 25, 2021 · Filed May 27, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect95,943 Reported balance After 2021-05-25 transaction · row 1
1 source row

Row 1 · 2021-05-25 · Grant · Acquired 12,056 · Balance 95,943

F1: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CASTLE BIOSCIENCES INC

Report date May 23, 2024 · Filed June 04, 2024

Section 16 reporting ended · disclosed 2024-06-04. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,139 Reported balance After 2024-05-23 transaction · row 1
1 source row

Row 1 · 2024-05-23 · Exercise / conversion · Acquired 8,636 · Balance 44,139

F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2024-05-23 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2024-05-23 · Exercise / conversion · Disposed 8,636 · Balance 0

F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2: Each consists of a grant of restricted stock units awarded to the Reporting Person on May 25th, 2023 under the "Non Employee Director Compensation Policy". Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continuous service with the Issuer, shares will be issuable to the Reporting Person upon the settlement of the restricted stock unit award, which vests in full on the earlier of (a) the one-year anniversary of the date of grant and (b) the day immediately preceding the next Annual Meeting of Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2: Each consists of a grant of restricted stock units awarded to the Reporting Person on May 25th, 2023 under the "Non Employee Director Compensation Policy". Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continuous service with the Issuer, shares will be issuable to the Reporting Person upon the settlement of the restricted stock unit award, which vests in full on the earlier of (a) the one-year anniversary of the date of grant and (b) the day immediately preceding the next Annual Meeting of Stockholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2025 Filed May 15, 2025 20:45 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 71,017 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009562 · form4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,758

F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 14, 2026, or (ii) immediately prior to the commencement of the Company's 2026 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 13, 2025 Filed May 15, 2025 20:45 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 6,666 $2.65 $17,681.57
Disclosure

SEC source: 0001062993-25-009562 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,741

F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

Read SEC document
May 23, 2024 Filed Jun 4, 2024 22:52 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000100 · wk-form4_1717541528.xml · derivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,636 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: Each consists of a grant of restricted stock units awarded to the Reporting Person on May 25th, 2023 under the "Non Employee Director Compensation Policy". Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continuous service with the Issuer, shares will be issuable to the Reporting Person upon the settlement of the restricted stock unit award, which vests in full on the earlier of (a) the one-year anniversary of the date of grant and (b) the day immediately preceding the next Annual Meeting of Stockholders.

F2 · derivative.expiration_date: Each consists of a grant of restricted stock units awarded to the Reporting Person on May 25th, 2023 under the "Non Employee Director Compensation Policy". Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continuous service with the Issuer, shares will be issuable to the Reporting Person upon the settlement of the restricted stock unit award, which vests in full on the earlier of (a) the one-year anniversary of the date of grant and (b) the day immediately preceding the next Annual Meeting of Stockholders.

Read SEC document
May 23, 2024 Filed Jun 4, 2024 22:52 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 8,636 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000100 · wk-form4_1717541528.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:47 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 24,691 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010481 · form4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,407

F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 14, 2025, or (ii) immediately prior to the commencement of the Company's 2025 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:47 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 6,619 $5.27 $34,849.04
Disclosure

SEC source: 0001062993-24-010481 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,716

F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 3,825 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000107 · wk-form4_1686084137.xml · derivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000107 · wk-form4_1686084137.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:38 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000080 · wk-form4_1685482670.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:21 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 24,517 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-011378 · form4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,335

F2 · shares: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 15, 2024, or (ii) immediately prior to the commencement of the Company's 2024 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:21 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 5,400 $5.62 $30,321.00
Disclosure

SEC source: 0001062993-23-011378 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,818

F1 · shares: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

Read SEC document
August 25, 2022 Filed Aug 31, 2022 12:42 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 PurchaseCommon Stock 6,000 $4.19 $25,137.60
Disclosure

SEC source: 0001062993-22-018891 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,218

F1 · shares: Represents shares of Common Stock purchased in the open market on August 25, 2022.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 23:02 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 830 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000113 · wf-form4_165516131716488.xml · derivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 830 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 10, 2022.

F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 10, 2022.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 23:02 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 830 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000113 · wf-form4_165516131716488.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,678

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2022 Filed Jun 6, 2022 20:09 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 6,745 $4.00 $26,998.21
Disclosure

SEC source: 0001062993-22-014388 · form4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,218

F2 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares.

Read SEC document
June 03, 2022 Filed Jun 6, 2022 20:09 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 24,983 $4.00 $99,999.45
Disclosure

SEC source: 0001062993-22-014388 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,963

F1 · kind: Restricted stock award vesting on June 3, 2022.

Read SEC document
June 02, 2022 Filed Jun 6, 2022 23:06 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 3,825 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000094 · wf-form4_165455679589646.xml · derivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,825

Underlying: Common Stock · 3,825 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023.

Read SEC document
June 02, 2022 Filed Jun 6, 2022 23:06 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 7,647 $0.00 Strike: $20.77 $0.00
Disclosure

SEC source: 0001447362-22-000094 · wf-form4_165455679589646.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,647

Underlying: Common Stock · 7,647 shares

Expires 2032-06-01

Read SEC document
May 16, 2022 Filed May 18, 2022 20:09 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 20,000 $5.25 $105,000.00
Disclosure

SEC source: 0001062993-22-012894 · form4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,980

F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2023. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:09 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 2,957 $5.25 $15,524.25
Disclosure

SEC source: 0001062993-22-012894 · form4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,980

F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:23 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 830 $0.00 $0.00
Disclosure

SEC source: 0001447362-21-000136 · wf-form4_162370219919092.xml · derivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 830

Underlying: Common Stock · 830 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 10, 2022.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on June 10, 2022.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:23 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 3,379 $0.00 Strike: $71.22 $0.00
Disclosure

SEC source: 0001447362-21-000136 · wf-form4_162370219919092.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,379

Underlying: Common Stock · 3,379 shares

Expires 2031-06-09

Read SEC document
May 25, 2021 Filed May 27, 2021 20:38 UTC Veradigm Inc. MDRX · Entity 13670 GrantCommon Stock 12,056 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-036258 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,943

F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Read SEC document
May 18, 2021 Filed May 19, 2021 20:11 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 10,952 $9.59 $105,002.30
Disclosure

SEC source: 0001593968-21-001358 · primary_01.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,937

F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 16, 2022. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:11 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 1,775 $9.50 $16,864.63
Disclosure

SEC source: 0001593968-21-001358 · primary_01.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,985

F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares

Read SEC document
October 02, 2020 Filed Oct 5, 2020 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,500 $52.48 $131,200.00
Disclosure

SEC source: 0001447362-20-000229 · wf-form4_160192840876661.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,848

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 1, 2020.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 20:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,500 $50.48 $126,200.00
Disclosure

SEC source: 0001447362-20-000217 · wf-form4_159985487374882.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,348

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 1, 2020.

Read SEC document
September 04, 2020 Filed Sep 9, 2020 20:06 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,500 $48.48 $121,200.00
Disclosure

SEC source: 0001447362-20-000209 · wf-form4_159968197259550.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,848

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 1, 2020.

Read SEC document
August 28, 2020 Filed Aug 31, 2020 20:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,500 $46.48 $116,200.00
Disclosure

SEC source: 0001447362-20-000197 · wf-form4_159890448085845.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,348

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 1, 2020.

Read SEC document
June 04, 2020 Filed Jun 8, 2020 16:34 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 8,000 $0.00 Strike: $37.50 $0.00
Disclosure

SEC source: 0001447362-20-000117 · wf-form4_159163403166177.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2030-06-03

Read SEC document
May 21, 2020 Filed May 22, 2020 20:35 UTC Veradigm Inc. MDRX · Entity 13670 GrantCommon Stock 30,582 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-031738 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,887

F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Read SEC document
May 18, 2020 Filed May 19, 2020 20:44 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 6,577 $15.97 $105,001.81
Disclosure

SEC source: 0001593968-20-001216 · primary_01.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,760

F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 17, 2021. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
May 15, 2020 Filed May 19, 2020 20:44 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 Tax withholdingCommon Stock 3,343 $16.04 $53,622.05
Disclosure

SEC source: 0001593968-20-001216 · primary_01.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,183

F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares

Read SEC document
July 29, 2019 Filed Jul 31, 2019 20:21 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 ConversionSeries F Preferred Stock · Derivative 17,180 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-043855 · doc4.xml · derivative · entry 3

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,093 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.

F1 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.

Read SEC document
July 29, 2019 Filed Jul 31, 2019 20:21 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 PurchaseCommon Stock 3,125 $16.00 $50,000.00
Disclosure

SEC source: 0001209191-19-043855 · doc4.xml · nonDerivative · entry 2

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,848

F2 · shares: Represents a purchase from the underwriters in the Issuer's IPO.

Read SEC document
July 29, 2019 Filed Jul 31, 2019 20:21 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 ConversionCommon Stock 14,093 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-043855 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.

Read SEC document
May 24, 2019 Filed May 29, 2019 20:57 UTC Veradigm Inc. MDRX · Entity 13670 GrantCommon Stock 19,628 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-033225 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,305

F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Read SEC document
May 21, 2019 Filed May 22, 2019 20:37 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon Stock 12,382 $8.48 $104,999.36
Disclosure

SEC source: 0001593968-19-001164 · primary_01.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,526

F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
December 14, 2018 Filed Dec 17, 2018 12:33 UTC Veradigm Inc. MDRX · Entity 13670 PurchaseCommon Stock 963 $10.39 $10,005.57
Disclosure

SEC source: 0001209191-18-062847 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,677

F1 · kind: These transactions were executed in multiple trades at prices ranging from $10.38 to $10.39. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
May 21, 2018 Filed May 23, 2018 20:33 UTC Veradigm Inc. MDRX · Entity 13670 GrantCommon Stock 15,949 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-032609 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,714

F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date.

Read SEC document
May 08, 2018 Filed May 10, 2018 20:22 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantCommon stock 6,144 Not disclosed Not disclosed
Disclosure

SEC source: 0001209784-18-000017 · edgar.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,144

F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

F1 · price: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Read SEC document
November 07, 2017 Filed Nov 9, 2017 22:11 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 PurchaseCommon stock 5,000 $14.23 $71,163.50
Disclosure

SEC source: 0001209784-17-000060 · edgar.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
June 21, 2017 Filed Jun 22, 2017 21:13 UTC ORASURE TECHNOLOGIES INC OSUR · Entity 6152 GrantNonqualified stock options · Derivative 40,000 Not disclosed Strike: $14.95 Not disclosed
Disclosure

SEC source: 0001209784-17-000051 · edgar.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common stock · 40,000 shares

Expires 2027-06-21

F1 · kind: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors.

F1 · price: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors.

F1 · derivative.exercise_date: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors.

Read SEC document
May 22, 2017 Filed May 24, 2017 20:35 UTC Veradigm Inc. MDRX · Entity 13670 GrantCommon Stock 16,765 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-034967 · doc4.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,765

F1 · kind: Restricted stock units award with vesting that will occur in twelve (12) equal monthly installments, commencing in June 2017. Distribution of the vested units is deferred pursuant to the Allscripts Healthcare Solutions, Inc. Director Deferred Compensation Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.